WuXi Biologics Competitors and Similar CompaniesClear all

WuXi Biologics's competitors and similar companies include Evotec, Catalent, Lonza, Samsung Biologics and Fujifilm Diosynth Biotechnologies.
WuXi Biologics
WuXi Biologics
WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
Evotec
Evotec
Evotec is a biotechnology company that provides drug discovery and development services.
Catalent
Catalent
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
Lonza
Lonza
Lonza Group is a company that supplies active ingredients, chemical intermediates, and biotechnology solutions to the pharmaceutical and agrochemical industries.
Samsung Biologics
Samsung Biologics
Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization.
Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
Founding Date
Founding Date
2010
Founding Date
1993
Founding Date
2007
Founding Date
1897
Founding Date
2011
Founding Date
2011
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Wuxi, CN HQ
George Town, KY
Wuppertal, DE
Hong Kong, HK
Dundalk, IE
Cranbury, US
King Of Prussia, US
Locations
Hamburg, DE HQ
Orth An Der Donau, AT
Lyon, FR
Toulouse, FR
Göttingen, DE
Halle (Westfalen), DE
Köln, DE
see more
Locations
Somerset, US HQ
Buenos Aires, AR
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
see more
Locations
Basel, CH HQ
Baulkham Hills, AU
Antwerpen, BE
Bornem, BE
Verviers, BE
Rio De Janeiro, BR
Dorval, CA
see more
Locations
Incheon, KR HQ
Boston, US
Ridgefield Park, US
South San Francisco, US
Locations
Morrisville, US HQ
Hillerød, DK
Stockton On Tees, GB
College Station, US
Employees
Employees
12,7403% increase
Employees
5,086
Employees
17,8006% decrease
Employees
18,000
Employees
4,284
Employees
4,4341% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.9 b
Valuation ($)
10 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
426
Twitter followers
3.9 k
Twitter followers
19 k
Twitter followers
8.1 k
Twitter followers
6
Twitter followers
2.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
32
Number of tweets (last 30 days)
116
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
23
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.3
Average likes per tweet (last 30 days)
4.1
Average likes per tweet (last 30 days)
0.4
Average likes per tweet (last 30 days)
15
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
90.91%
Percentage of tweets with engagement (last 30 days)
96.88%
Percentage of tweets with engagement (last 30 days)
33.62%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
82.61%

Financial

Revenue (est.)
Revenue (est.)
¥17b (FY, 2023)
Revenue (est.)
€781.4m (FY, 2023)
Revenue (est.)
$4.3b (FY, 2023)
Revenue (est.)
CHF6.7b (FY, 2023)
Revenue (est.)
₩3.7t (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
¥8.8b (FY, 2023)
Cost of goods
€564.3m (FY, 2023)
Cost of goods
$3.2b (FY, 2023)
Cost of goods
CHF4.1b (FY, 2023)
Cost of goods
₩1.9t (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
¥8.4b (FY, 2023)
Gross profit
€281.9m (FY, 2023)
Gross profit
$1b (FY, 2023)
Gross profit
CHF2.6b (FY, 2023)
Gross profit
₩1.8t (FY, 2023)
Gross profit
N/A
Net income
Net income
¥3.6b (FY, 2023)
Net income
(€83.9m) (FY, 2023)
Net income
($256m) (FY, 2023)
Net income
CHF655m (FY, 2023)
Net income
₩857.7b (FY, 2023)
Net income
N/A

Operating

Backlog
Backlog
$18.5b (H1, 2022)
Backlog
N/A
Backlog
$2.5b (FY, 2023)
Backlog
N/A
Backlog
N/A
Backlog
N/A
Countries
Countries
N/A
Countries
N/A
Countries
80 (FY, 2023)
Countries
28 (FY, 2022)
Countries
N/A
Countries
N/A
Customers
Customers
N/A
Customers
842 (FY, 2021)
Customers
1.2 k (FY, 2023)
Customers
N/A
Customers
N/A
Customers
N/A
Products
Products
N/A
Products
130 (FY, 2021)
Products
8 k (FY, 2023)
Products
N/A
Products
N/A
Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 993.6m
Total funding raised
$ 650m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 850m
For sources of this data, please see the company profile

View Company Profiles

Evotec
HQ
Hamburg, DE
Employees
5,086

Evotec is a biotechnology company that provides drug discovery and development services.

View company
Catalent
HQ
Somerset, US
Employees
17,800↓ 6% decrease

Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.

View company
Lonza
HQ
Basel, CH
Employees
18,000

Lonza Group is a company that supplies active ingredients, chemical intermediates, and biotechnology solutions to the pharmaceutical and agrochemical industries.

View company
Samsung Biologics
HQ
Incheon, KR
Employees
4,284

Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization.

View company